CervoMed Inc.CRVONASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P36
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025-41.86%
2024-121.89%
2023-189.57%
202282.26%
2021-7.00%
2020-37.47%
20198.49%
201812.65%
2017-14.52%
2016-107.67%